The inhibition of NFKB1, which acts as a transcription factor in the SEC14L3 promoter and enhancer regions, further suppresses SEC14L3 expression, establishing a positive feedback loop of SEC14L3/RPS3/NFκB that collectively inhibits ccRCC progression. This evidence concerns the gene SEC14L3 and nonpapillary renal cell carcinoma.